Rise Advisors’s British American Tobacco BTI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-71
Closed -$2.94K 1561
2025
Q1
$2.94K Buy
71
+1
+1% +$39 ﹤0.01% 1166
2024
Q4
$2.54K Buy
70
+2
+3% +$72 ﹤0.01% 1068
2024
Q3
$2.5K Buy
68
+1
+1% +$36 ﹤0.01% 1118
2024
Q2
$2.07K Sell
67
-280
-81% -$8.51K ﹤0.01% 1121
2024
Q1
$10.6K Buy
347
+8
+2% +$241 0.01% 1040
2023
Q4
$9.92K Buy
339
+8
+2% +$243 0.01% 318
2023
Q3
$10.4K Buy
331
+7
+2% +$231 0.01% 312
2023
Q2
$10.8K Buy
324
+7
+2% +$239 0.01% 330
2023
Q1
$11.1K Sell
317
-166
-34% -$6.26K 0.01% 346
2022
Q4
$19.3K Sell
483
-473
-49% -$18.6K 0.02% 255
2022
Q3
$34K Buy
956
+159
+20% +$6.37K 0.03% 191
2022
Q2
$34K Buy
+797
New +$34.2K 0.03% 174

Other funds holding BTI

Rise Advisors's BTI Position: Q2 2025 in Review

Rise Advisors sold out of British American Tobacco (BTI) in Q2 2025, closing a stake of 71 shares — an estimated $2.94K sold.

Rise Advisors first reported a position in BTI in Q2 2022 and held it in 12 quarters. The position peaked at $34K in Q3 2022. 717 funds tracked by Wall St. Rank hold BTI as of Q2 2025.

  • Rise Advisors reported no remaining British American Tobacco position as of Q2 2025 after selling out during the quarter.
  • Rise Advisors sold 71 British American Tobacco shares in Q2 2025, an estimated $2.94K.
  • Rise Advisors first reported a position in British American Tobacco in Q2 2022 and held it in 12 quarters.
  • Rise Advisors's British American Tobacco position peaked at $34K in Q3 2022.
  • 717 funds tracked by Wall St. Rank held British American Tobacco as of Q2 2025.

Based on Rise Advisors's 13F filing for Q2 2025, filed 8 Jul 2025.